| General Information of Drug Metabolite (DM) (ID: DM006035) |
| DM Name |
Apli-dm
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 2A6 (CYP2A6)
|
DME0005
|
| Oxidation - C-dealkylation |
Y-100032
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Y-100032 |
DR1309
|
Phase 3 |
Multiple myeloma |
|
|
| References |
| 1 |
In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug. Invest New Drugs. 2007 Feb;25(1):9-19.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
